| Dr Arnon E Rubin, MD | |
|
700 E Ogden Ave, Ste 202, Westmont, IL 60559-5569 | |
| (630) 789-9785 | |
| (630) 789-9798 |
| Full Name | Dr Arnon E Rubin |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 27 Years |
| Location | 700 E Ogden Ave, Westmont, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245217413 | NPI | - | NPPES |
| 036101131 | Medicaid | IL | |
| 290015341 | Other | IL | MEDICARE RAILROAD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Glenoaks | Glendale heights, IL | Hospital |
| Adventist Bolingbrook Hospital | Bolingbrook, IL | Hospital |
| Adventist Hinsdale Hospital | Hinsdale, IL | Hospital |
| Adventist La Grange Memorial Hospital | La grange, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Suburban Pulmonary And Sleep Associates Ltd | 3476531088 | 23 |
News Archive
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that the US Food and Drug Administration has accepted its Investigational New Drug application to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease. The Company plans to initiate the Phase 3 study in the US in H1 2014 and positive data would be the cornerstone of a subsequent NDA submission.
People with learning (intellectual) disabilities have historically been marginalised from mainstream society, and have had limited choice and control over their lives. While movements to achieve greater equality have had success, the rapid advancement of modern technology risks creating a new form of digital exclusion.
Research scientists have developed a novel method to re-create brain and intestinal stem cells from patients who died decades ago, using DNA from stored blood samples to study the potential causes of debilitating illnesses such as inflammatory bowel disease.
"A plan by the University of California, Berkeley to voluntarily test the DNA of incoming freshman has come under fire from critics who said the school was pushing an unproven technology on impressionable students. The university has said it will send test kits to 5,500 new students to analyze genes that help control the body's responses to alcohol, dairy products and folic acid" (Wohlsen, 5/21).
An app that allows parents and doctors to monitor a child's asthma has a big impact on managing the disease.
› Verified 4 days ago
| Entity Name | Suburban Pulmonary & Sleep Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649283896 PECOS PAC ID: 3476531088 Enrollment ID: O20040709001417 |
News Archive
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that the US Food and Drug Administration has accepted its Investigational New Drug application to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease. The Company plans to initiate the Phase 3 study in the US in H1 2014 and positive data would be the cornerstone of a subsequent NDA submission.
People with learning (intellectual) disabilities have historically been marginalised from mainstream society, and have had limited choice and control over their lives. While movements to achieve greater equality have had success, the rapid advancement of modern technology risks creating a new form of digital exclusion.
Research scientists have developed a novel method to re-create brain and intestinal stem cells from patients who died decades ago, using DNA from stored blood samples to study the potential causes of debilitating illnesses such as inflammatory bowel disease.
"A plan by the University of California, Berkeley to voluntarily test the DNA of incoming freshman has come under fire from critics who said the school was pushing an unproven technology on impressionable students. The university has said it will send test kits to 5,500 new students to analyze genes that help control the body's responses to alcohol, dairy products and folic acid" (Wohlsen, 5/21).
An app that allows parents and doctors to monitor a child's asthma has a big impact on managing the disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arnon E Rubin, MD 700 E Ogden Ave, Ste 202, Westmont, IL 60559-5569 Ph: (630) 789-9785 | Dr Arnon E Rubin, MD 700 E Ogden Ave, Ste 202, Westmont, IL 60559-5569 Ph: (630) 789-9785 |
News Archive
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that the US Food and Drug Administration has accepted its Investigational New Drug application to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease. The Company plans to initiate the Phase 3 study in the US in H1 2014 and positive data would be the cornerstone of a subsequent NDA submission.
People with learning (intellectual) disabilities have historically been marginalised from mainstream society, and have had limited choice and control over their lives. While movements to achieve greater equality have had success, the rapid advancement of modern technology risks creating a new form of digital exclusion.
Research scientists have developed a novel method to re-create brain and intestinal stem cells from patients who died decades ago, using DNA from stored blood samples to study the potential causes of debilitating illnesses such as inflammatory bowel disease.
"A plan by the University of California, Berkeley to voluntarily test the DNA of incoming freshman has come under fire from critics who said the school was pushing an unproven technology on impressionable students. The university has said it will send test kits to 5,500 new students to analyze genes that help control the body's responses to alcohol, dairy products and folic acid" (Wohlsen, 5/21).
An app that allows parents and doctors to monitor a child's asthma has a big impact on managing the disease.
› Verified 4 days ago
Laisvyde Smajkic, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 801 N Cass Ave, Ste 150, Westmont, IL 60559 Phone: 630-268-0200 | |
Dr. Vasantha Samala, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 700 E Ogden Ave, Suite 202, Westmont, IL 60559 Phone: 630-789-9785 Fax: 630-789-9798 | |
Dr. Brandon William Segrest, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 700 E Ogden Ave Ste 202, Westmont, IL 60559 Phone: 630-528-3215 Fax: 630-528-3219 | |
Andrew Yu, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 303 W Ogden Ave Ste D12, Westmont, IL 60559 Phone: 630-871-6699 | |
Erum Arain, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 700 E Ogden Ave Ste 202, Westmont, IL 60559 Phone: 630-789-9785 | |
Melwin Joseph, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 700 E Ogden Ave Ste 202, Westmont, IL 60559 Phone: 630-528-3215 Fax: 630-528-3219 |